Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,216
Closed -$398K 379
2025
Q4
$398K Buy
1,216
+203
+20% +$64.4K 0.23% 172
2025
Q3
$286K Buy
1,013
+288
+40% +$83.5K 0.17% 272
2025
Q2
$202K Buy
+725
New +$205K 0.11% 396
2024
Q4
Sell
-679
Closed -$219K 43
2024
Q3
$219K Buy
+679
New +$222K 0.12% 353
2023
Q3
Sell
-1,521
Closed -$338K 424
2023
Q2
$338K Buy
+1,521
New +$353K 0.23% 178
2023
Q1
Sell
-3,354
Closed -$881K 398
2022
Q4
$881K Sell
3,354
-17
-0.5% -$4.56K 0.6% 21
2022
Q3
$760K Buy
+3,371
New +$817K 0.49% 36

Other funds holding AMGN

MQS Management's AMGN Position: Q1 2026 in Review

MQS Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,216 shares — an estimated $398K sold.

MQS Management first reported a position in AMGN in Q3 2022 and held it in 7 quarters. The position peaked at $881K in Q4 2022. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • MQS Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • MQS Management sold 1,216 Amgen shares in Q1 2026, an estimated $398K.
  • MQS Management first reported a position in Amgen in Q3 2022 and held it in 7 quarters.
  • MQS Management's Amgen position peaked at $881K in Q4 2022.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.